Oct 21 (Reuters) - Biotech company 10x Genomics (TXG.O), opens new tab filed two lawsuits against rival Illumina (ILMN.O), opens new tab in Delaware federal court on ...

ABSTRACT: Inflammatory bowel diseases (IBD) are complex multifactorial disorders that include Crohn’s disease (CD) and ulcerative colitis (UC). Considering that IBD is a genetic and multifactorial ...

Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2023 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, ...

SAN FRANCISCO—Illumina’s new CEO Jacob Thaysen, PhD, shared the sequencing giant’s 2024 priorities and presented preliminary fourth-quarter and full-year 2023 results that beat Wall Street forecasts ...

Susan Tousi has left Illumina to take up the CEO post at Delfi Diagnostics. The move puts Tousi in charge of commercializing the lead liquid biopsy from a company that could compete with Grail, the ...

Single-cell sequencing includes the isolation of a single cell and studying its sequence information with the latest sequencing technologies to fully characterize cells and gain invaluable insight ...

Illumina has steadily driven down the cost of sequencing, hailing the advent of the $1,000 genome with the unveiling of its HiSeq X Ten machine in 2014 and now following up with news of a further drop ...

Clinical research frequently uses tissue that has been formalin-fixed and paraffin-embedded (FFPE). Due to the destructive nature of the formalin fixation process, where crosslinking, chemical ...

Metagenome assembly is a core yet methodologically challenging step for taxonomic classification and functional annotation of a microbiome. This study aims to generate the high-resolution human gut ...